EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Comorbidities and comorbidity burden in patients with neurocognitive disorders: findings from the MEMORA Cohort Study

Mohamed Nour Temedda, Antoine Garnier-Crussard, Claire Moutet, Christelle Mouchoux, Virginie Dauphinot

European Geriatric Medicine · 2025

DOI: 10.1007/s41999-025-01288-8 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Geriatric Medicine, 2025. Verfasst von Mohamed Nour Temedda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Research Memory Center of Lyon, Charpennes Hospital, Department of Geriatric Medicine, Lyon Institute For Aging, Hospices Civils de Lyon…. Hauptthemen laut MEDLINE: Neurocognitive Disorders, Dementia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospices Civils de Lyon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to compare comorbidities’ prevalence and the comorbidity burden as measured by comorbidity indices according to the stages and the etiological diagnoses of neurocognitive disorders (NCD). This study aimed also to examine how comorbidities and comorbidity indices were associated with both stages and etiologies of NCD.

Methods

This is a cross-sectional study including participants from the MEMORA real-life cohort, aged ≥ 60 years. Patients had to be in either MCI or dementia stage, with the following etiological diagnoses of NCD: AD, VD (vascular dementia), mixed dementia (MD), dementia with Lewy bodies, frontotemporal dementia and Parkinson’s disease. Three comorbidity indices were used to measure comorbidity burden: the Charlson comorbidity index, the multimorbidity-weighted index (MWI) and the health-related quality of life comorbidity index (HRQOL-CI). Prevalence of comorbidities involved in the calculation of at least one comorbidity index were reported. The associations between comorbidities/comorbidity indices and groups were assessed using binary and multinomial logistic regressions.

Results

Overall, 3470 patients (66.9% dementia; 50.9% AD) were included. The most frequent comorbidities were hypertension (50.2%), depression (28.0%) and hypercholesterolemia (22.6%). The MWI and the HRQOL-CI were associated with increased odds of dementia (vs. MCI). Upon stratifying population according to the etiological diagnoses of NCD, the highest mean of the three comorbidity indices were found in patients with VD and MD.

Conclusion

Comorbidities and comorbidity burden vary according to the stage and etiological diagnoses of NCD. Future studies should consider the stage and the etiological diagnoses, when studying the effect of the comorbidity burden on the progression of NCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurocognitive DisordersDementiaHumansMaleFemaleCross-Sectional StudiesAgedComorbidityMiddle AgedPrevalenceQuality of LifeAged, 80 and overCohort StudiesCognitive DysfunctionSpainHypertension

Stichwörter der Autor:innen

ComorbiditiesComorbidity indicesDementiaMCINeurocognitive disorders

Autor:innen und Institutionen

  • Clinical and Research Memory Center of Lyon, Charpennes Hospital, Department of Geriatric Medicine, Lyon Institute For Aging, Hospices Civils de Lyon, Lyon 1 University, 27 rue Gabriel Péri, 69100, Villeurbanne, France.…
  • INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Center, Brain Dynamics and Cognition Team, University Lyon 1, 69000, Lyon, France. mohamed-nour.temedda@chu-lyon.fr.
  • Clinical Research Center Ageing-Brain-Frailty, University Claude Bernard Lyon 1, Hospices Civils de Lyon, 69100, Villeurbanne, France. mohamed-nour.temedda@chu-lyon.fr.
  • Clinical and Research Memory Center of Lyon, Charpennes Hospital, Department of Geriatric Medicine, Lyon Institute For Aging, Hospices Civils de Lyon, Lyon 1 University, 27 rue Gabriel Péri, 69100, Villeurbanne, France.
  • Clinical Research Center Ageing-Brain-Frailty, University Claude Bernard Lyon 1, Hospices Civils de Lyon, 69100, Villeurbanne, France.
  • Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", NeuroPresage Team, Institute Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Förderung

  • Hospices Civils de Lyon

Zitieren

APA

Temedda, M. N., Garnier-Crussard, A., Moutet, C., Mouchoux, C., & Dauphinot, V. (2025). Comorbidities and comorbidity burden in patients with neurocognitive disorders: findings from the MEMORA Cohort Study. European Geriatric Medicine. https://doi.org/10.1007/s41999-025-01288-8

Vancouver

Temedda MN, Garnier-Crussard A, Moutet C, Mouchoux C, Dauphinot V. Comorbidities and comorbidity burden in patients with neurocognitive disorders: findings from the MEMORA Cohort Study. European Geriatric Medicine. 2025. doi:10.1007/s41999-025-01288-8

BibTeX
@article{Temedda2025,
  author = {Temedda, Mohamed Nour and Garnier-Crussard, Antoine and Moutet, Claire and Mouchoux, Christelle and Dauphinot, Virginie},
  title = {Comorbidities and comorbidity burden in patients with neurocognitive disorders: findings from the MEMORA Cohort Study},
  journal = {European Geriatric Medicine},
  year = {2025},
  doi = {10.1007/s41999-025-01288-8}
}
Kostenlos starten →